lomustine has been researched along with Rhabdomyosarcoma 2 in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Identification of synchronous brain tumors prompted genetic testing for predisposition to malignancy." | 1.35 | De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system. ( Brat, DJ; Esiashvili, N; Janss, AJ; Schniederjan, MJ; Shehata, B, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schniederjan, MJ | 1 |
| Shehata, B | 1 |
| Brat, DJ | 1 |
| Esiashvili, N | 1 |
| Janss, AJ | 1 |
1 other study available for lomustine and Rhabdomyosarcoma 2
| Article | Year |
|---|---|
De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma; Choroid Plex | 2009 |